Fundraising FoxMedical Devices Startups
7,455 companies tagged Medical Devices, with their investors and founders.
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research. The company builds implantable neurotechnology aimed at clinical applications.
31 investors
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum. The company serves oncologists and patients in women's health diagnostics.
30 investors
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception. The company works on translational reproductive biology research to bring new contraceptive options to market.
26 investors
BillionToOne builds a DNA molecular counting technology that increases the resolution of cell-free DNA diagnostics, applied to prenatal screening and liquid biopsy for cancer. Its products serve clinical genetic testing in prenatal care and oncology.
22 investors
Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
22 investors
Andromeda Surgical develops an AI-guided surgical platform that provides GPS-like navigation and autonomous task capabilities to surgeons, starting with endourology procedures. The platform integrates with existing surgical tools to assist interventional surgeons in performing procedures with enhanced precision and reduced training requirements.
21 investors
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions. The company was founded in 2025 through a strategic combination of atai Life Sciences and Beckley Psytech.
21 investors
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases. The company serves healthcare providers and patients seeking preventive cancer screening solutions.
21 investors
Science Corporation develops brain-computer interface and neural engineering technology to restore vision, cognition, and mobility to patients with debilitating conditions. The company also provides components and vertically integrated infrastructure through Science Foundry to support innovation across the neural technology industry.
21 investors
Hinge Health builds a digital healthcare platform designed to help individuals manage musculoskeletal health and related conditions. The company serves health plans, employers, and individuals seeking alternative healthcare approaches.
19 investors
Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind. The company's device is under clinical investigation, including studies funded by the U.S. Department of Defense related to PTSD.
19 investors
Eko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy. The company serves clinicians and health systems seeking advanced diagnostic tools for cardiac care.
18 investors
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes. The company uses stem cell biology and in vitro maturation techniques to create innovative solutions for patients seeking family-building options.
18 investors
Rad AI develops generative AI models and automation solutions specifically designed for radiology and healthcare workflows. The platform helps physicians and health systems reduce radiologist burnout, save time, and improve patient care.
18 investors
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets. The company focuses on expanding its pipeline of novel therapeutic medicines by leveraging macrocycle chemistry and pharmacokinetics.
17 investors
FidoCure provides precision medicine for canine oncology, offering genetic sequencing and targeted therapies that enable veterinarians to treat dogs with cancer. It operates a US network of veterinary clinics and oncologists for both cancer diagnostics and treatment.
16 investors
GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear. The test is offered by prescription in the United States and through partnerships with healthcare systems, insurance carriers, and diagnostic platforms.
16 investors
Guardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.
16 investors
Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
16 investors
Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
15 investors
Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology. The company serves laboratories, food brands, healthcare systems, and diagnostic organizations.
15 investors
Opentrons builds pipetting robots that automate laboratory experiments for biologists and the scientific community. Its platform lets researchers share protocols and reproduce experimental results instead of performing repetitive benchwork by hand.
15 investors
Paperspace is a cloud computing company that provides a platform for building, deploying, and scaling AI and other computationally intensive applications. It serves individuals and professional teams with accelerated computing resources.
15 investors
Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams. The platform enables clinical laboratories and life sciences organizations to improve workflow efficiency, support remote collaboration, and integrate artificial intelligence tools for quantitative tissue analysis and biomarker detection.
15 investors